Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC

Name: Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC
License: Public Domain

Karie Runcie

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

advanced renal cell carcinoma, metastatic renal cell carcinoma, clear cell renal cell carcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 140993
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.